Latest Valuation News

Asra Minerals has completed a comprehensive target generation exercise at its Leonora Gold Projects, identifying 26 priority drill-ready gold targets and securing regulatory approval to commence drilling in Q2 2025. The company also strengthened its balance sheet with a $3 million placement and asset sale proceeds.

Trinex Minerals has identified promising lithium soil geochemistry trends at its Dudley Lithium Project and secured approvals for drilling, while completing a key share issuance for its Canadian East Yellowknife Lithium Project.

1414 Degrees Ltd advances its transformation into a full-service decarbonised energy provider, delivering key technology and commercial milestones in Q3 FY25 while maintaining a stable cash position.

Norwest Minerals has been granted a key mining lease for its Bulgera Gold Project and launched a $4.85 million entitlement offer to fund aggressive resource drilling and mining evaluations. Meanwhile, exploration at West Arunta reveals promising titanium and base metal intersections, underpinning the company’s growth ambitions.

Adavale Resources has completed the acquisition of a 72.5% stake in the Parkes Gold and Copper Project, delivering promising early exploration results and securing $722,000 in new funding to support upcoming drilling programs.

Minerals 260 Limited has completed a transformative $220 million capital raise alongside acquiring the Bullabulling Gold Project, positioning itself as a significant gold developer with a 2.3 million ounce resource. The company has launched an extensive 80,000-metre drilling program to unlock further resource potential.

DXN Limited reported a modest 2% revenue increase to $2.5 million in Q3 FY25, launched its Data Centre as a Service division with a $3.6 million initial contract, and progressed a key acquisition valued at $10 million, positioning itself for growth despite some project delays.

MedAdvisor Solutions reported a challenging third quarter with steep revenue declines, driven by delayed program launches and US sales underperformance, but is executing a strategic overhaul and cost-cutting measures to position for a rebound and 15% revenue growth in FY26.

MedAdvisor Limited reports a steep decline in 3Q FY25 revenue, driven by US market challenges, while accelerating cost-cutting and reaffirming full-year guidance.

Reef Casino Trust’s responsible entity confirms ongoing confidential negotiations with two parties over potential acquisition proposals exceeding A$200 million, though no deal is assured.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

Impact Minerals reports significant progress across multiple fronts, including a major nickel-copper-PGM anomaly at Arkun and nearing completion of the Lake Hope High Purity Alumina pre-feasibility study.